Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LifeRx.md vs REMEVi

LifeRx.md
Graded #133

Lower grade

vs+1.1000000000000085
REMEVi
Graded #105

Higher grade

The verdict

REMEVi takes it — 70.4/100 to 69.3/100, but only just.

REMEVi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated. LifeRx.md is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLifeRx.md +3
57
54
Dose & formulationLifeRx.md +8
72
64
Clinical oversightEven
86
86
Labs & monitoringREMEVi +3
62
65
FulfillmentREMEVi +16
81
97
Contract termsREMEVi +14
55
69
LifeRx.md · left barREMEVi · right bar

The numbers

MetricLifeRx.mdREMEVi
WeighScore69.3/10070.4/100
GradeCC
Scorecard rank#133#105
Semaglutide$200/mo$199/mo (starting dose, compounded)
Tirzepatide$275/mo$269/mo (starting dose, compounded)
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
LifeRx.md

Graded #133 · C

Strengths

  • Flat pricing that does not rise with dose: semaglutide ~$200, tirzepatide ~$275 per 5-week supply
  • LegitScript certified; prescriptions filled by state-licensed 503A pharmacies
  • Available in all 50 states
  • HSA and FSA payments accepted
  • Required video telehealth consult ensures clinician oversight

Where it loses points

  • Compounded GLP-1s are not FDA-approved for safety, efficacy or quality
  • Extra fees stack up: ~$30 shipping, $49.95 initial consult, $25 follow-ups
  • True monthly cost (~$255) is higher than the headline medication price
  • Specific list of supported states not enumerated on site
REMEVi

Graded #105 · C

Strengths

  • The first bilingual GLP-1 clinic — care delivered in English and Spanish by clinicians trained in both, not auto-translated
  • Compounded semaglutide from $199/mo and tirzepatide from $269/mo on the 52-week plan, with the same price every month (no titration price hikes)
  • LegitScript-certified and licensed in all 50 states + DC, with an NPI-verified pharmacy and overnight shipping
  • Transparent all-inclusive pricing with no hidden fees and cancel anytime; full legal suite (Privacy, Terms, HIPAA, Refund)

Where it loses points

  • Lowest pricing requires a 52-week commitment — month-to-month is higher ($279 semaglutide / $339 tirzepatide)
  • Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy or Zepbound
  • The specific compounding pharmacy is not named (described as 'NPI-verified')
  • A newer, patient-founded clinic; press mentions (Fortune, AP, Reuters) are syndicated PR, not editorial endorsements

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard